Literature DB >> 15253384

Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor.

Timothy E Adams1, Neil M McKern, Colin W Ward.   

Abstract

The type 1 insulin-like growth factor receptor (IGF-1R) plays an essential role in mammalian growth and development, and has emerged as a candidate therapeutic target in the treatment of cancer. While the pleiotropic cellular responses elicited following tyrosine phosphorylation of the IGF-1R is usually seen to involve the direct recruitment/activation of classical intracellular effector proteins, it is now clear that cross-talk between the IGF-1R and members of distinct receptor families also plays a significant role in effecting intracellular signalling. In recent years, a number of studies have highlighted the interaction(s) between the IGF-1R and the epidermal growth factor receptor (EGFR), another transmembrane tyrosine kinase that is an established cancer target. This review describes the components of the IGF signalling system and gives an overview of the emerging picture of the interrelationship that is now known to exist between the IGF and EGF receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253384     DOI: 10.1080/08977190410001700998

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  33 in total

1.  History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.

Authors:  Marni Stott-Miller; Chu Chen; Shu-Chun Chuang; Yuan-Chin Amy Lee; Stefania Boccia; Hermann Brenner; Gabriela Cadoni; Luigino Dal Maso; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Keitaro Matsuo; Hal Morgenstern; Heiko Müller; Joshua Muscat; Andrew F Olshan; Mark P Purdue; Diego Serraino; Thomas L Vaughan; Zuo-Feng Zhang; Paolo Boffetta; Mia Hashibe; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

2.  Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.

Authors:  Yi Peter Hu; Sandip B Patil; Michelle Panasiewicz; Wenhui Li; Jennie Hauser; Lisa E Humphrey; Michael G Brattain
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

3.  Simultaneous reconstruction of multiple signaling pathways via the prize-collecting steiner forest problem.

Authors:  Nurcan Tuncbag; Alfredo Braunstein; Andrea Pagnani; Shao-Shan Carol Huang; Jennifer Chayes; Christian Borgs; Riccardo Zecchina; Ernest Fraenkel
Journal:  J Comput Biol       Date:  2013-02       Impact factor: 1.479

4.  Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody.

Authors:  Dong Hoon Shin; Hye-Young Min; Adel K El-Naggar; Scott M Lippman; Bonnie Glisson; Ho-Young Lee
Journal:  Mol Cancer Ther       Date:  2011-10-06       Impact factor: 6.261

5.  Expression patterns of As-ClC gene of Artemia sinica in early development and under salinity stress.

Authors:  Qiaozhi Zhang; Ming Hou; Qiuying Li; Lulu Han; Zhe Yuan; Jian Tan; Bin Du; Xiangyang Zou; Lin Hou
Journal:  Mol Biol Rep       Date:  2013-01-01       Impact factor: 2.316

6.  Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

Authors:  Dong Hoon Shin; Hyo-Jong Lee; Hye-Young Min; Sun Phil Choi; Mi-Sook Lee; Jung Weon Lee; Faye M Johnson; Kapil Mehta; Scott M Lippman; Bonnie S Glisson; Ho-Young Lee
Journal:  J Natl Cancer Inst       Date:  2013-10-03       Impact factor: 13.506

7.  A comprehensive salivary analysis for oral cancer diagnosis.

Authors:  Thomas Shpitzer; Gideon Bahar; Raphael Feinmesser; Rafael M Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

8.  Genome profiling of ERBB2-amplified breast cancers.

Authors:  Fabrice Sircoulomb; Ismahane Bekhouche; Pascal Finetti; José Adélaïde; Azza Ben Hamida; Julien Bonansea; Stéphane Raynaud; Charlène Innocenti; Emmanuelle Charafe-Jauffret; Carole Tarpin; Farhat Ben Ayed; Patrice Viens; Jocelyne Jacquemier; François Bertucci; Daniel Birnbaum; Max Chaffanet
Journal:  BMC Cancer       Date:  2010-10-08       Impact factor: 4.430

9.  Biologic response of human intervertebral disc cells to gene therapy cocktail.

Authors:  Seong-Hwan Moon; Kotaro Nishida; Lars G Gilbertson; Hwan-Mo Lee; Hyang Kim; Ronald A Hall; Paul D Robbins; James D Kang
Journal:  Spine (Phila Pa 1976)       Date:  2008-08-01       Impact factor: 3.468

10.  Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

Authors:  Doris R Siwak; Mark Carey; Bryan T Hennessy; Catherine T Nguyen; Mollianne J McGahren Murray; Laura Nolden; Gordon B Mills
Journal:  J Oncol       Date:  2009-11-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.